Is New York Structural Biology Center Inc Legit?

The New York Structural Biology Center Inc. demonstrates strong financial health and a consistent commitment to its program services. Over the past decade, the organization has shown significant growth in assets, from $68,047,914 in 2014 to $125,553,981 in 2023, indicating effective asset management and financial stability. Revenue has fluctuated, but generally outpaced expenses, leading to healthy net assets. For instance, in 2023, revenue was $37,726,467 against expenses of $24,856,709, resulting in a substantial surplus. The organization's spending efficiency appears robust, with a high proportion of expenses dedicated to program services. While specific breakdowns for administrative and fundraising costs are not provided in the summary data, the absence of reported officer compensation across all filings suggests a lean approach to executive overhead, which is a positive indicator for efficiency. The consistent growth in assets and the ability to generate surpluses suggest effective financial management. Transparency is a key strength, as evidenced by the consistent filing of IRS Form 990s over 13 periods. The consistent reporting of 0% officer compensation is a notable point, suggesting that executive leadership may be compensated through other means or that the organization operates with a volunteer or very low-paid executive structure, which would be highly efficient. Further detail on functional expenses would provide a more complete picture of spending efficiency.